{"id":12378,"date":"2018-08-09T15:51:02","date_gmt":"2018-08-09T19:51:02","guid":{"rendered":"https:\/\/www.transy.edu\/1780\/?p=12378"},"modified":"2025-05-27T11:20:00","modified_gmt":"2025-05-27T15:20:00","slug":"french-major-to-biotech-ceo","status":"publish","type":"post","link":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/","title":{"rendered":"French major to biotech CEO"},"content":{"rendered":"\n

David Hysong \u201909<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a cerebral MacGyver with entrepreneurial gifts, a strong faith and a desire to put himself on the line for others. <\/p>\n\n\n\n

Hysong has worked undercover in Cambodia to fight human trafficking. He founded an NGO to help refugee children. After being hit by a 12-ton bus, he managed to walk again, attend Harvard Divinity School and was selected for Navy SEAL training.<\/p>\n\n\n\n

In the past two years Hysong has become founder, CEO and patient of Shepherd Therapeutics<\/a>, a biotech company with offices in Nashville and Boston, created to find cures for rare forms of cancer. Diagnosed with a head and neck cancer that has no targeted therapy, Hysong quickly assessed the limitations within the existing oncological landscape. He traded special operations in the military for a different kind of warfare.<\/p>\n\n\n\n

The 250 forms of \u201crare\u201d cancer actually comprise 42 percent of all cancer diagnoses, Hysong notes. Together, they are the third leading cause of death in the U.S. Even so, the pharmaceutical industry neglects rare cancers in order to invest in fewer therapies affecting larger numbers of patients.<\/p>\n\n\n\n

Hysong could see the life-saving opportunities being missed. He created Shepherd Therapeutics to revolutionize how rare cancers are treated and the ecosystem around them. Operating with low overhead and a big-picture idea that connects existing resources, Shepherd Therapeutics identifies viable research then contracts scientists and labs to develop therapies.<\/p>\n\n\n\n

The idea for a company that is \u201cplatform agnostic\u201d rather than focused on one form of cancer, has raised $6.5 million from investors in the first year. Hysong also plans to create a nonprofit arm that will consistently feed 10 percent of the company\u2019s profits back into the work of foundations that fund research.<\/p>\n\n\n\n

“I had no idea that the ability to think outside the box creatively would help me build a biotech company” \u2014David Hysong, founder, CEO and patient of Shepherd TherapeuticsSo, how does a French major and liberal arts graduate become a biotech entrepreneur who is celebrated as a Forbes 30 under 30<\/a>? And how does a newly diagnosed cancer patient step up to redefine therapeutics for patients who have been left to fend for themselves?<\/p>\n\n\n\n

Growing up the son of a decorated military pilot, Hysong was a self-described \u201cboy\u2019s boy covered in mud\u201d and a romantic idealist who played his first Shakespearean lead, Hamlet, in the eighth grade. Shakespeare introduced him to the world of literature, to stories of knighthood and service and to poetry that would strengthen his resolve during monumental challenges in his life.<\/p>\n\n\n\n

\u201cI was able to imagine who I wanted to become\u2014this ideal Renaissance man\u2014and the life I wanted to live. And I did that largely through books,\u201d Hysong explains. \u201cI had no idea that the ability to think outside the box creatively would help me build a biotech company.\u201d<\/p>\n\n\n\n

On his company\u2019s website is a nod to Dylan Thomas, \u201cDo not go gentle into that good night,\u201d a poem he remembers from his first year at Transylvania. At Transy, Hysong says he found his spark to make learning a lifelong endeavor. \u201cThe biggest thing,\u201d he says, \u201cis that I was given the freedom\u2014the intellectual autonomy\u2014 encouragement and resources\u201d to do it all.<\/p>\n\n\n\n

Hysong earned a master\u2019s in liberal arts from St. John\u2019s College in Annapolis before being critically injured by a bus in Cambodia while investigating child slavery. Given little expectation that he would ever walk again, he began two years of intensive physical rehabilitation, rebuilding his life from scratch. It was one of two times in his life that required nothing less than a form of resurrection, he acknowledges.<\/p>\n\n\n\n

Then, on a friend\u2019s dare, he applied to Harvard Divinity School while convalescing, typing his entry essay with one hand. \u201cI wanted to study faith for myself,\u201d he says. As he worked on his degree in religion, ethics and politics, and his body strengthened, his call to military service returned. He completed the grueling application process and was chosen from among 40 civilians to join the Navy\u2019s special forces. But he also learned that he accomplished this feat with adenoid cystic carcinoma.<\/p>\n\n\n\n

Hysong says that faith, the legacy of his father\u2019s heroism, education and literature are driving forces for him. The camaraderie, leadership and self-sacrifice that once drew him to the military now take shape in the form of Shepherd Therapeutics and its expert team that vows \u201cto never stop fighting until every rare cancer patient lives.\u201d<\/p>\n\n\n\n

The goal of Shepherd Therapeutics, says Hysong, is to save one million lives over the next decade. \u201cI think I\u2019ve found my place to stand,\u201d he affirms. “I think I’ll be here for a while.”<\/p>\n","protected":false},"excerpt":{"rendered":"

David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a cerebral MacGyver with entrepreneurial gifts, a strong faith and a desire to put himself on the line for others.  Hysong has worked undercover in Cambodia to fight human trafficking. He founded an NGO to help refugee children. After being hit by a 12-ton bus, he managed to walk again, attend Harvard Divinity School and was selected for Navy SEAL training. In the past two years Hysong has become founder, CEO and patient of Shepherd Therapeutics, a biotech company with offices in Nashville and Boston, created to find cures for rare forms of cancer. Diagnosed with a head and neck cancer that has no targeted therapy, Hysong quickly assessed the limitations within the existing oncological landscape. He traded special operations in the military for a different kind of warfare. The 250 forms of \u201crare\u201d cancer actually comprise 42 percent of all cancer diagnoses, Hysong notes. Together, they are the third leading cause of death in the U.S. Even so, the pharmaceutical industry neglects rare cancers in order to invest in fewer therapies affecting larger numbers of patients. Hysong could see the life-saving opportunities being missed. He created Shepherd Therapeutics to revolutionize how rare cancers are treated and the ecosystem around them. Operating with low overhead and a big-picture idea that connects existing resources, Shepherd Therapeutics<\/p>\n

Read “French major to biotech CEO”<\/a><\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"3982,1291,1559,8523,3458,1741","_relevanssi_noindex_reason":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"feeds":[],"class_list":["post-12378","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\nFrench major to biotech CEO - Transylvania University - 1780<\/title>\n<meta name=\"description\" content=\"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"French major to biotech CEO\" \/>\n<meta property=\"og:description\" content=\"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"1780\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/transylvaniauniversity\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-09T19:51:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T15:20:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2020\/06\/site-logo_400.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Office of Marketing and Communications\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@transy\" \/>\n<meta name=\"twitter:site\" content=\"@transy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Office of Marketing and Communications\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/\"},\"author\":{\"name\":\"Office of Marketing and Communications\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/#\\\/schema\\\/person\\\/e76dbb827bcc6f86e2b86e67c9162ac7\"},\"headline\":\"French major to biotech CEO\",\"datePublished\":\"2018-08-09T19:51:02+00:00\",\"dateModified\":\"2025-05-27T15:20:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/\"},\"wordCount\":805,\"articleSection\":[\"News from Transy\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/\",\"url\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/\",\"name\":\"French major to biotech CEO - Transylvania University - 1780\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/#website\"},\"datePublished\":\"2018-08-09T19:51:02+00:00\",\"dateModified\":\"2025-05-27T15:20:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/#\\\/schema\\\/person\\\/e76dbb827bcc6f86e2b86e67c9162ac7\"},\"description\":\"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/2018\\\/08\\\/french-major-to-biotech-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"French major to biotech CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/#website\",\"url\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/\",\"name\":\"1780\",\"description\":\"The Official Blog of Transylvania University\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.transy.edu\\\/1780\\\/#\\\/schema\\\/person\\\/e76dbb827bcc6f86e2b86e67c9162ac7\",\"name\":\"Office of Marketing and Communications\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"French major to biotech CEO - Transylvania University - 1780","description":"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/","og_locale":"en_US","og_type":"article","og_title":"French major to biotech CEO","og_description":"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a","og_url":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/","og_site_name":"1780","article_publisher":"https:\/\/www.facebook.com\/transylvaniauniversity","article_published_time":"2018-08-09T19:51:02+00:00","article_modified_time":"2025-05-27T15:20:00+00:00","og_image":[{"url":"https:\/\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2020\/06\/site-logo_400.png","width":400,"height":400,"type":"image\/png"}],"author":"Office of Marketing and Communications","twitter_card":"summary_large_image","twitter_creator":"@transy","twitter_site":"@transy","twitter_misc":{"Written by":"Office of Marketing and Communications","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/#article","isPartOf":{"@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/"},"author":{"name":"Office of Marketing and Communications","@id":"https:\/\/www.transy.edu\/1780\/#\/schema\/person\/e76dbb827bcc6f86e2b86e67c9162ac7"},"headline":"French major to biotech CEO","datePublished":"2018-08-09T19:51:02+00:00","dateModified":"2025-05-27T15:20:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/"},"wordCount":805,"articleSection":["News from Transy"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/","url":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/","name":"French major to biotech CEO - Transylvania University - 1780","isPartOf":{"@id":"https:\/\/www.transy.edu\/1780\/#website"},"datePublished":"2018-08-09T19:51:02+00:00","dateModified":"2025-05-27T15:20:00+00:00","author":{"@id":"https:\/\/www.transy.edu\/1780\/#\/schema\/person\/e76dbb827bcc6f86e2b86e67c9162ac7"},"description":"David Hysong \u201909 David Hysong \u201909 has always lived large and largely for others. He could easily be the inspiration for a liberal arts action figure, a","breadcrumb":{"@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.transy.edu\/1780\/2018\/08\/french-major-to-biotech-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.transy.edu\/1780\/"},{"@type":"ListItem","position":2,"name":"French major to biotech CEO"}]},{"@type":"WebSite","@id":"https:\/\/www.transy.edu\/1780\/#website","url":"https:\/\/www.transy.edu\/1780\/","name":"1780","description":"The Official Blog of Transylvania University","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.transy.edu\/1780\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.transy.edu\/1780\/#\/schema\/person\/e76dbb827bcc6f86e2b86e67c9162ac7","name":"Office of Marketing and Communications"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":1788,"url":"https:\/\/www.transy.edu\/1780\/2008\/09\/forces-of-habit-why-we-make-war-on-some-drugs-but-not-others\/","url_meta":{"origin":12378,"position":0},"title":""Forces of Habit: Why we make war on some drugs but not others"","author":"Office of Marketing and Communications","date":"September 27, 2008","format":false,"excerpt":"LEXINGTON, Ky.\u2014David Courtwright, John A. Delaney presidential professor at the University of Northern Florida, will give a lecture titled \u201cForces of Habit: Why we make war on some drugs but not others,\u201d at Transylvania University on Thursday, October 2, at 7:30 p.m. in the Cowgill Center, room 102. The lecture\u2026","rel":"","context":"In "News from Transy"","block_context":{"text":"News from Transy","link":"https:\/\/www.transy.edu\/1780\/category\/news\/"},"img":{"alt_text":"David Courtwright","src":"https:\/\/i0.wp.com\/www.transy.edu\/sites\/default\/files\/news\/images\/illustrations\/courtwright_photo_small.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1790,"url":"https:\/\/www.transy.edu\/1780\/2008\/09\/transylvanias-fall-convocation-speaker-david-walton-presents-a-purpose-driven-life\/","url_meta":{"origin":12378,"position":1},"title":"Transylvania’s fall convocation speaker, David Walton, presents "A Purpose Driven Life"","author":"Office of Marketing and Communications","date":"September 12, 2008","format":false,"excerpt":"LEXINGTON, Ky.\u2014Doctor, humanitarian and global health expert David Walton presented, \u201cLiving a Purpose Driven Life,\u201d in Transylvania\u2019s Haggin Auditorium on Sunday, September 14, at 7 p.m. The lecture was free and open to the public. This lecture, Transylvania\u2019s fall convocation, tied in with Transy\u2019s First Engagement\u2019s book choice for 2008-09,\u2026","rel":"","context":"In "News from Transy"","block_context":{"text":"News from Transy","link":"https:\/\/www.transy.edu\/1780\/category\/news\/"},"img":{"alt_text":"David Walton","src":"https:\/\/i0.wp.com\/www.transy.edu\/sites\/default\/files\/news\/images\/illustrations\/walton.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1555,"url":"https:\/\/www.transy.edu\/1780\/2012\/09\/yale-history-professor-david-blight-to-present-on-the-civil-war-at-transylvania-university-on-monday-sept-17\/","url_meta":{"origin":12378,"position":2},"title":"Yale History Professor David Blight to present on the Civil War at Transylvania University on Monday, Sept. 17","author":"Office of Marketing and Communications","date":"September 12, 2012","format":false,"excerpt":"LEXINGTON, Ky.\u2014The Kentucky Civil War Round Table and Transylvania University will host a presentation by David Blight Monday, Sept. 17 at 6:30 p.m. in the Mitchell Fine Arts Center's Haggin Auditorium. The lecture is titled \u201cCivil War and Emancipation in American Memory, Then and Now.\u201d Blight is a professor of\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/www.transy.edu\/1780\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.transy.edu\/sites\/default\/files\/news\/images\/illustrations\/Blight_1.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":7913,"url":"https:\/\/www.transy.edu\/1780\/2019\/09\/in-memoriam-david-jones-transylvania-trustee-and-faculty-development-benefactor\/","url_meta":{"origin":12378,"position":3},"title":"In Memoriam: David Jones, Transylvania trustee and faculty development benefactor","author":"Office of Marketing and Communications","date":"September 18, 2019","format":false,"excerpt":"David Jones, a former Transylvania trustee, had a long history of supporting Kentucky\u2019s oldest university, especially in areas benefiting faculty professional development.","rel":"","context":"In "News from Transy"","block_context":{"text":"News from Transy","link":"https:\/\/www.transy.edu\/1780\/category\/news\/"},"img":{"alt_text":"David Jones and Charles Shearer","src":"https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/Jones_Shearer-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1795,"url":"https:\/\/www.transy.edu\/1780\/2009\/11\/transylvania-university-board-of-trustees-names-presidential-search-committee\/","url_meta":{"origin":12378,"position":4},"title":"Transylvania University Board of Trustees names presidential search committee","author":"Office of Marketing and Communications","date":"November 19, 2009","format":false,"excerpt":"LEXINGTON, Ky.\u2014Transylvania University Board of Trustees Chairman William T. Young Jr. announced today a 14-member search committee for the 25th president of the 229-year old liberal arts college. Transylvania\u2019s longest tenured president, Charles L. Shearer, announced to the board in October that he would retire as president at the end\u2026","rel":"","context":"In "Faculty & Staff"","block_context":{"text":"Faculty & Staff","link":"https:\/\/www.transy.edu\/1780\/category\/faculty-staff\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7883,"url":"https:\/\/www.transy.edu\/1780\/2019\/09\/former-lexington-mayor-jim-gray-to-give-transylvanias-convocation-speech-thursday\/","url_meta":{"origin":12378,"position":5},"title":"Former Lexington Mayor Jim Gray to give Transylvania’s convocation speech Thursday","author":"John Friedlein","date":"September 17, 2019","format":false,"excerpt":"Former Lexington Mayor Jim Gray will deliver the keynote address during Transylvania University's Academic Convocation at 4:30 p.m. Thursday in Haggin Auditorium.","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/www.transy.edu\/1780\/category\/events\/"},"img":{"alt_text":"Jim Gray","src":"https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.transy.edu\/1780\/wp-content\/uploads\/sites\/14\/2019\/09\/190916_Headshot_JimGrayDSC_4560_Small-2.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/posts\/12378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/comments?post=12378"}],"version-history":[{"count":2,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/posts\/12378\/revisions"}],"predecessor-version":[{"id":25094,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/posts\/12378\/revisions\/25094"}],"wp:attachment":[{"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/media?parent=12378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/categories?post=12378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/tags?post=12378"},{"taxonomy":"feeds","embeddable":true,"href":"https:\/\/www.transy.edu\/1780\/wp-json\/wp\/v2\/feeds?post=12378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}